Annual EBITDA
$28.16B$1.49B-5.01%
Summary
- Current Value
- As of today, JNJ annual EBITDA is $28.16B, down -5.01% on
- Historical Performance
- JNJ annual EBITDA is down -11.64% over the past 3 years, and down -1.39% over the past 5 years
- All-Time High Comparison
- JNJ annual EBITDA is currently -11.64% below its historical high of $31.87B set on
- 3-Year Low Comparison
- JNJ annual EBITDA is at its 3-year low
- Sector Comparison
- JNJ annual EBITDA is higher than 100.00% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $28.16B | -5.0% | -11.6% | -1.4% | +45.2% | |
| Quarterly EBITDA | $8.89B | +27.7% | +25.2% | +14.3% | +83.5% | |
| TTM EBITDA | $31.15B | +8.0% | +4.2% | +4.8% | +58.9% | |
| Price | $207.49 | +41.9% | +15.1% | +29.4% | +231.4% | |
| PE Ratio | 20.02 | -20.6% | -25.2% | -31.2% | +52.8% | |
| Annual Revenue | $88.82B | +4.3% | -5.3% | +8.2% | +43.4% | |
| Annual EPS | $5.79 | +4.6% | -25.8% | +2.8% | +31.6% | |
| Annual EBIT | $20.82B | -6.0% | -14.9% | -3.4% | +25.2% | |
| Annual Net Income | $14.07B | +5.5% | -32.6% | -7.0% | +14.7% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $29.65B | -5.0% | |
| 5Y | $31.87B | -11.6% | |
| All | $31.87B | -11.6% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $28.16B | at low | |
| 5Y | $27.70B | N/A | +1.7% |
| All | $754.80M | +3631.1% |
EBITDA History
FAQ
What is the current annual EBITDA of JNJ?
As of today, JNJ annual EBITDA is $28.16B
What is 1-year change in JNJ annual EBITDA?
JNJ annual EBITDA is down -5.01% year-over-year
What is 3-year change in JNJ annual EBITDA?
JNJ annual EBITDA is down -11.64% over the past 3 years
How far is JNJ annual EBITDA from its all-time high?
JNJ annual EBITDA is currently -11.64% below its historical high of $31.87B set on December 31, 2021
How does JNJ annual EBITDA rank versus sector peers?
JNJ annual EBITDA is higher than 100.00% of companies in Healthcare sector
When is JNJ next annual earnings release?
The next annual earnings release for JNJ is on
Quarterly EBITDA
$8.89B$107.00M+1.22%
Summary
- Current Value
- As of today, JNJ quarterly EBITDA is $8.89B, up +1.22% on
- Historical Performance
- JNJ quarterly EBITDA is up +27.68% year-over-year, and up +25.21% over the past 3 years
- All-Time High Comparison
- JNJ quarterly EBITDA is currently at its all-time high
- 3-Year Low Comparison
- JNJ quarterly EBITDA is +64.25% above its 3-year low of $5.41B reached on
- Sector Comparison
- JNJ quarterly EBITDA is higher than 100.00% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $8.89B | +1.2% | +27.7% | +25.2% | +14.3% | |
| Annual EBITDA | $28.16B | – | -5.0% | -11.6% | -1.4% | |
| TTM EBITDA | $31.15B | +6.6% | +8.0% | +4.2% | +4.8% | |
| Price | $207.49 | +9.8% | +41.9% | +15.1% | +29.4% | |
| PE Ratio | 20.02 | +9.8% | -20.6% | -25.2% | -31.2% | |
| Quarterly Revenue | $23.99B | +1.1% | +6.8% | +19.9% | +13.8% | |
| Quarterly EPS | $2.12 | -7.3% | +91.2% | +26.6% | +59.3% | |
| Quarterly EBIT | $7.10B | +3.8% | +38.7% | +31.1% | +19.0% | |
| Quarterly Net Income | $5.15B | -7.0% | +91.2% | +19.5% | +45.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $8.89B | at high | |
| 3Y | $8.89B | at high | |
| 5Y | $8.89B | at high | |
| All | $8.89B | at high |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $5.41B | N/A | +64.3% |
| 3Y | $5.41B | +64.3% | |
| 5Y | $5.41B | +64.3% | |
| All | -$5.40B | +264.7% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of JNJ?
As of today, JNJ quarterly EBITDA is $8.89B
What is JNJ quarterly EBITDA most recent change?
JNJ quarterly EBITDA was up +1.22% on September 30, 2025
What is 1-year change in JNJ quarterly EBITDA?
JNJ quarterly EBITDA is up +27.68% year-over-year
How far is JNJ quarterly EBITDA from its all-time high?
JNJ quarterly EBITDA is currently at its all-time high
How does JNJ quarterly EBITDA rank versus sector peers?
JNJ quarterly EBITDA is higher than 100.00% of companies in Healthcare sector
When is JNJ next earnings release?
The next earnings release for JNJ is on
TTM EBITDA
$31.15B$1.93B+6.59%
Summary
- Current Value
- As of today, JNJ TTM EBITDA is $31.15B, up +6.59% on
- Historical Performance
- JNJ TTM EBITDA is up +7.95% year-over-year, and up +4.19% over the past 3 years
- All-Time High Comparison
- JNJ TTM EBITDA is currently -2.96% below its historical high of $32.10B set on
- 3-Year Low Comparison
- JNJ TTM EBITDA is +10.34% above its 3-year low of $28.23B reached on
- Sector Comparison
- JNJ TTM EBITDA is higher than 100.00% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $31.15B | +6.6% | +8.0% | +4.2% | +4.8% | |
| Annual EBITDA | $28.16B | – | -5.0% | -11.6% | -1.4% | |
| Quarterly EBITDA | $8.89B | +1.2% | +27.7% | +25.2% | +14.3% | |
| Price | $207.49 | +9.8% | +41.9% | +15.1% | +29.4% | |
| PE Ratio | 20.02 | +9.8% | -20.6% | -25.2% | -31.2% | |
| TTM Revenue | $92.15B | +1.7% | +5.1% | -0.2% | +14.0% | |
| TTM EPS | $10.36 | +10.8% | +71.3% | +44.2% | +62.8% | |
| TTM EBIT | $23.75B | +9.1% | +10.1% | +4.0% | +4.9% | |
| TTM Net Income | $25.12B | +10.8% | +70.1% | +32.1% | +47.9% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $31.15B | at high | |
| 3Y | $31.15B | at high | |
| 5Y | $32.10B | -3.0% | |
| All | $32.10B | -3.0% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $28.23B | N/A | +10.3% |
| 3Y | $28.23B | +10.3% | |
| 5Y | $27.70B | N/A | +12.5% |
| All | -$1.90B | +1743.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of JNJ?
As of today, JNJ TTM EBITDA is $31.15B
What is JNJ TTM EBITDA most recent change?
JNJ TTM EBITDA was up +6.59% on September 30, 2025
What is 1-year change in JNJ TTM EBITDA?
JNJ TTM EBITDA is up +7.95% year-over-year
How far is JNJ TTM EBITDA from its all-time high?
JNJ TTM EBITDA is currently -2.96% below its historical high of $32.10B set on December 31, 2021
How does JNJ TTM EBITDA rank versus sector peers?
JNJ TTM EBITDA is higher than 100.00% of companies in Healthcare sector
When is JNJ next earnings release?
The next earnings release for JNJ is on
EBITDA Formula
Data Sources & References
- JNJ Official Website www.jnj.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/200406/000020040625000038/0000200406-25-000038-index.htm
- JNJ Profile on Yahoo Finance finance.yahoo.com/quote/JNJ
- JNJ Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/jnj